We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics Trigger Antigen Presentation and CXCL1-Mediated Inflammation in Glioma Tumor-Associated Myeloid Cells
Original title: Microplastics Trigger Antigen Presentation and CXCL1-Mediated Inflammation in Glioma Tumor-Associated Myeloid Cells 2260962
AI summary Read the abstract
In mice with brain tumors, injecting microplastic particles directly into the tumor woke up immune cells that had been "switched off" by the cancer, prompting them to start flagging threats again and triggering inflammation. This is early, exploratory research (in mice, not people) that doesn't tell us microplastics are good or bad for brain tumor patients — but it hints that these ubiquitous plastic particles can meaningfully interact with our immune system in ways scientists are only beginning to understand.
Abstract Introduction Glioblastoma, a WHO grade IV glioma, is a lethal tumor with a 5-year survival rate below 7 percent, largely due to its immunosuppressive tumor microenvironment (TME). Tumor-associated myeloid cells contribute significantly to this immunosuppressive environment by downregulating key antigen-presenting markers, including MHC II, CD80, and CD86. Developing literature on macrophage activation indicates that microplastics, once phagocytosed, play a key role. We hypothesize that microplastic particles will activate macrophages within the tumor microenvironment after intertumoral injection. Methods To test this, we used a murine intracranial glioma model, implanted on day 0 and intratumorally injected with fluorescent microplastics 10 days after implantation. Brain and lymphoid organs were harvested 24 hours after and analyzed using flow cytometry and bulk RNA sequencing. Results Plastics directly induced upregulation of activation markers MHC II and costimulatory markers CD80 and CD86 in microplastic-treated mice compared with sham-treated mice. The largest subpopulation of myeloid cells was neutrophils, which showed upregulation of activation markers indicative of antigen presentation, a phenomenon traditionally not observed in neutrophils. Bulk RNA sequencing also reveals a strong emphasis on neutrophil activation, with upregulation of the activation and recruitment marker CXCL1. Conclusion Our finding suggests that myeloid cells in the TME retain the ability to respond to acute stimuli by upregulating antigen presentation markers. Through CXCL1 upregulation, microplastics activate inflammation responses in myeloid cells, particularly neutrophils. We conclude that microplastics could induce myeloid activation and provide novel therapeutic insight into brain tumor biology. Funding Source N/A Topic Categories Tumor Immunology: Checkpoints, Prevention, and Treatment (TIPT)
More Papers Like This
Role of microplastics in the tumor microenvironment (Review)
AI summary Read the abstract
This review examines how microplastics may help tumors grow by influencing the environment around cancer cells. Microplastics can interact with immune cells, connective tissue cells, blood vessel cells, and the tissue scaffolding around tumors in ways that may promote cancer progression and inflammation. While more research is needed, the findings raise important questions about whether chronic microplastic exposure could affect cancer development in humans.
Brain tissue near tumours is loaded with plastic
AI summary Read the abstract
Scientists found more tiny plastic particles (called micro- and nanoplastics) in brain tissue near tumors compared to healthy brain tissue. This might mean the brain's natural protective shield, the "blood-brain barrier," which normally keeps harmful substances out, breaks down near tumors, letting more plastic particles slip through. This is early research, but it raises questions about whether plastics in our environment could affect brain health, especially in people with tumors.
Microglial phagocytosis of polystyrene microplastics results in immune alteration and apoptosis in vitro and in vivo
AI summary Read the abstract
Researchers found that polystyrene microplastics can cross the blood-brain barrier in mice after oral exposure and accumulate in brain tissue, where they are engulfed by microglia, the brain's immune cells. This engulfment triggered inflammatory responses and cell death in the microglia both in cell cultures and in living mice. The study suggests that microplastic exposure may affect brain immune function, with potential implications for neurological health.
Effects of microplastics on the colorectal tumor immune microenvironment and immunotherapy resistance via JAK–STAT–microbiota perturbation.
AI summary Read the abstract
Scientists found that microplastics—tiny plastic particles now common in our environment—can build up in colorectal (colon) tumors and make cancer immunotherapy less effective, based on studies in mice. The plastics seem to weaken the immune system's ability to find and attack cancer cells, partly by disrupting gut bacteria and blocking key immune signals. While this research was done in animals rather than people, it raises concerning questions about whether everyday plastic exposure could affect cancer treatment outcomes in humans.
Polystyrene nanoplastics induce transient microglial activation via endolysosomal retention in the mouse cortex
AI summary Read the abstract
Tiny plastic particles from everyday pollution can reach the brain and temporarily rev up its immune cells, according to a mouse study, with larger particles causing more disruption to genes involved in brain signaling. This suggests that as microplastics build up in our environment, they may quietly affect brain health, even after exposure stops, making plastic pollution a growing concern worth watching.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.